Onderneming Stellar Biotechnologies Inc Toronto S.E.
Aandelen
KLH
CA85855A2039
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Michael Brooks
PSD | President | 46 | 01-09-15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15-07-23 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-16 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 01-01-19 |
Raj Puri
PRN | Corporate Officer/Principal | - | 23-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07-06-19 |
Frank Oakes
BRD | Director/Board Member | 73 | 09-04-10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-23 |
Joan Chypyha
BRD | Director/Board Member | 57 | 23-05-23 |
Charles Olson
BRD | Director/Board Member | 66 | 23-05-23 |
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Carlo Sistilli
CHM | Chairman | 67 | 07-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 215 968 | 2 301 084 ( 71,55 %) | 0 | 71,55 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,66% | 109 mld. | |
+11,23% | 105 mld. | |
-0,38% | 22,25 mld. | |
-12,15% | 22,09 mld. | |
-7,66% | 18,68 mld. | |
-36,52% | 17,58 mld. | |
-10,09% | 16,85 mld. | |
+3,33% | 13,76 mld. | |
+36,58% | 12,46 mld. |